Answers are grounded in this paper and cite their sources.
Objective To estimate the incidence, diagnostic features, and perinatal outcomes of massive subchorionic thrombohematoma (MST) in Japan. Methods This nationwide multicenter retrospective study (2018–2023) analyzed confirmed cases of MST, defined as a laminated hematoma with a maximum thickness ≥1 cm. Maternal characteristics, sonographic patterns, and perinatal complications were evaluated. Results Of 346 741 deliveries across 87 tertiary perinatal centers, 69 pathologically confirmed MST cases were identified at 27 centers, yielding an incidence of 0.019% (69/346 741). Median maternal age was 33 years and body mass index (BMI) was 21.1. Chronic hypertension was present in 8.7% (6/69). Diagnoses occurred antenatally in 81.2% (56/69) and postpartum in 18.8% (13/69). Ultrasound findings included placentomegaly or a placental mass with variable echogenicity. During follow‐up, echogenicity changed in 28% of cases and lesion size in 57%. Perinatal outcomes included induced abortion in 13.0% (9/69), miscarriage before 22 weeks in 5.8% (4/69), stillbirth in 7.2% (5/69), preterm birth in 52.2% (36/69), and term delivery in 21.7% (15/69). Among preterm births, one neonatal death and two infant deaths occurred. After excluding induced abortion and miscarriage before 22 weeks, small‐for‐gestational‐age status was present in 53.6% (30/56) of infants, pre‐eclampsia occurred in 16.1% (9/56), and preterm premature rupture of membranes occurred in 23.2% (13/56). Neonatal intensive care unit admission was required for 82.4% (42/51) of live births. Conclusion MST is a rare but high‐risk placental disorder associated with miscarriage, stillbirth, preterm birth, impaired fetal growth, and pre‐eclampsia. When MST is suspected antenatally, close maternal and fetal surveillance is warranted.
No takes yet. Share an insight, caveat, or question.
Nagao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: